3SBio, a China partner of U.S. drug giant Pfizer, has reached agreements to raise approximately $400 million in a share ...

Holmes’ attack on evidence that led to her conviction comes amid an apparent campaign to obtain a pardon from President ...

These five stocks are potential total return champions that could offer investors a smooth ride in 2026, as we could see some ...

Pfizer's strategy that will help it rebound from recent struggles is in full motion. It says a lot that the company continues ...

Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:00 a.m. EST on Tuesday, December 16, 2025. The ...

Pfizer offers value with a strong dividend, Metsera obesity expansion, PADCEV/Keytruda approval, and an oncology pipeline.

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

Most of the dividend increases announced in the last two weeks of November were in the low-to-mid single-digit percentages.

Founded 170 years ago and currently headquartered in New York, Pfizer Inc. (PFE) is a global biopharmaceutical powerhouse ...